Black Hawk Acquisition Corporation Class A Ordinary Shares (BKHA)

About BKHA

Black Hawk Acquisition Corporation is a blank check company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2023 and is based in Danville, California.

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Website

www.bhspac.com

Fundamentals

1-day range

Market cap

$—

P/E (trailing)

98.17

P/E (forward)

—

EPS (trailing)

$0.12

Dividend yield

—

Beta

0.04

Avg. volume

920

Black Hawk Acquisition Corporation Class A Ordinary Shares Competitors

Chosen by industry and closest market cap.

• BKHA

  Black Hawk Acquisition Corporation Class A Ordinary Shares

  $11.85

  ▼ 0.28%
  Market cap $—P/E 98.17
  $10.98$13.1
• SCNI

  Scinai Immunotherapeutics Ltd. American Depositary Shares

  $2.53

  ▼ 5.60%
  Market cap $1.37MP/E 0.14
  $2.15$16.8
• VIVS

  VivoSim Labs Inc. Common Stock

  $0.29

  ▲ 0.00%
  Market cap $4.03MP/E —
  $0.2625$5.3
• PHGE

  BiomX Inc. COmmon Stock

  $0.138

  ▲ 4.55%
  Market cap $4.62MP/E —
  $0.1192$12.29
• BCAB

  BioAtla Inc. Common Stock

  $1.79

  ▼ 42.99%
  Market cap $5.41MP/E —
  $2.81$71.5
• AIM

  AIM ImmunoTech Inc. Common Stock

  $0.2558

  ▲ 2.32%
  Market cap $7.32MP/E —
  $0.1901$2.89
• BCDA

  BioCardia Inc. Common Stock

  $1.16

  ▼ 0.85%
  Market cap $9.45MP/E —
  $0.75$2.29

P/E shows — for peers not currently carrying a live signal of their own.